Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Histamine H1 antagonists

A B Fleischer

    The New England Journal of Medicine
    |October 13, 1994
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Baseline patient-reported outcomes from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2019
    Same author

    An evidence-based review of systemic treatments for itch.

    European journal of pain (London, England)·2015
    Same author

    Diagnosed skin diseases among migrant farmworkers in North Carolina: prevalence and risk factors.

    Journal of agricultural safety and health·2007
    Same author

    Prescribing practices for seborrheic dermatitis vary with the physician's specialty: implications for clinical practice.

    The Journal of dermatological treatment·2005
    Same author

    Racial differences in the treatment of pigmentation disorders in outpatient settings: analysis of US national practice data.

    The Journal of dermatological treatment·2005
    Same author

    Class I topical corticosteroid use by psoriasis patients in an academic practice.

    The Journal of dermatological treatment·2005
    Same journal

    Advances in Multiple Sclerosis.

    The New England journal of medicine·2026
    Same journal

    Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.

    The New England journal of medicine·2026
    Same journal

    Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.

    The New England journal of medicine·2026
    Same journal

    Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia.

    The New England journal of medicine·2026
    See all related articles